This Award Notice opportunity from Department Of Defense was posted on August 28, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

MECLIZINE HYDROCHLORIDE TABLETS

Awarded

SPE2D926F8450Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Antibodies Elution Kit Supplier (NSN 6550-01-346-4878)This subcontract involves the supply of finished Antibodies Elution Kits, identified by NSN 6550-01-346-4878, for prime contractors serving the Department of Defense Medical Supply Chain. The required kits must contain concentrated wash, eluting, and buffering solutions designed for the rapid acid elution of antibodies from red blood cells. All deliverables must strictly adhere to FDA regulations, MIL-STD-2073-1E packaging requirements, and Medical Marking Standard No. 1. The scope of work requires the delivery of two complete kits to Keesler AFB, with each kit maintaining a minimum shelf-life of one month. This procurement falls under NAICS code 325412 and is managed through the DLA Troop Support Medical Supply Chain.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Gabapentin Capsules SupplyThis subcontract involves the supply of FDA-regulated Gabapentin Capsules (100 MG) to support prime contractors on Department of Defense medical supply chain projects. The scope of work requires the manufacture or procurement of ten bottles of capsules that strictly adhere to FDA regulations and USP Controlled Room Temperature standards of 25 degrees Celsius. To maintain a non-extendable shelf life of 36 months, all products must be handled in FDA-approved facilities and transported using climate-monitored shipping containers. The contract is managed by the Medical Supply Chain Pharm FSA and requires full compliance with the Buy American Act. Performance will take place in Washington, DC, under NAICS code 325412. Interested parties must note the response deadline of November 16, 2026, to ensure all regulatory and delivery specifications are met for this pharmaceutical procurement.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Hypoallergenic Soft Tissue Massage CreamThis subcontract involves the supply of non-greasy, hypoallergenic soft tissue massage cream for prime contractors supporting the Medical Supply Chain Pharm FSA under the Department of Defense. The supplier must provide products that strictly adhere to FDA regulations and meet the specifications of NSN 6508017007944. To ensure product integrity, items must be stored in heated environments maintained at 40 degrees Fahrenheit or above. The contract requires the delivery of six 15 oz containers to Fort Polk, Louisiana, on a FOB Destination basis. All packaging and labeling must comply with MIL-STD-2073-1E, MIL-STD-129, and Medical Marking Standard No. 1. This procurement falls under NAICS code 325412, with a response deadline set for November 16, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Povidone-Iodine Cleansing Solution ManufacturerThis subcontract involves the manufacture and supply of Povidone-Iodine Cleansing Solution for prime contractors supporting MEDICAL SUPPLY CHAIN PHARM FSA projects under the Department of Defense. The solution must be produced according to USP standards, featuring a 7.5% active ingredient and a shelf life of 36 months. The product is to be delivered in one-gallon bottles, which must include SDS and Hazardous Communication Standard labels in accordance with 29 C.F.R. 1910.1200. Additionally, the manufacturer must ensure full compliance with the Buy American Act. Performance for this contract is designated for FPO 96665.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pan-Africa Polyvalent Antivenin SupplierThis subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the supply of Pan-Africa polyvalent equine F(ab)2 immunoglobulin fragments antivenin. The biological therapeutics are designed to treat snakebite envenomation from 25 different species and are intended for prime contractors fulfilling DLA supply contracts. The delivery requirement consists of 6 cases containing a total of 216 vials, shipped FOB Destination. To qualify, the supplier must possess pharmaceutical manufacturing facilities and maintain strict compliance with FDA regulatory approvals. Additionally, all deliverables must adhere to MIL-STD-2073-1E and RP001 DLA Packaging Requirements. The contract falls under NAICS code 325412, with a response deadline set for November 16, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

POVIDONE-IODINE CLEANS

Solicitation # SPE2DP-27-T-0271

This procurement involves the supply of Povidone-Iodine Cleansing Solution, USP, with a 7.5% active ingredient for external use. The product must be delivered in one-gallon bottles with a total shelf life of 36 months, ensuring at least 31 months remain upon delivery to the first government activity. Storage must be maintained at 25 degrees Fahrenheit, with permitted excursions between 15 and 30 degrees Celsius. The contract specifies delivery to the USS Harpers Ferry and USS Carter Hall, with a required delivery timeline of 20 days and FOB Destination terms. The contractor must adhere to strict packaging and marking standards, utilizing Medical Marking Standard No. 1 and MIL-STD-129. Hazardous materials must be packaged according to TQ requirement IP025 and FED-STD-313, and suppliers are required to submit Safety Data Sheets and Hazardous Communication Standard labels per 29 C.F.R. 1910.1200 prior to award. The contract is governed by various FAR and DFARS clauses, including requirements for safeguarding covered defense information, compliance with the Buy American Act, and the prohibition of covered defense telecommunications equipment. All payment requests must be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

VARICELLA VIRUS VACCIN

Solicitation # SPE2DP-27-T-0243

Solicitation SPE2DP-27-T-0243 is a small business set-aside request for quotation issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of one package of lyophilized Varicella Virus Vaccine Live (NSN 6505-01-413-1331). Each package must contain 10 single dose vials of live vaccine and 10 vials of diluent, totaling 20 vials. The product, manufactured by Merck Sharp & Dohme LLC, is FDA regulated and must be drop shipped directly from the manufacturer to the destination in Camp Zama, Japan, within 20 days after order. The vaccine is a Type I Code K item with a non-extendable shelf life of 18 months, with a requirement that no more than 15 months have elapsed from the date of manufacture to the date of delivery. Strict storage and handling protocols are required, including maintaining a frozen temperature between -50C and -15C. Packaging must be commercial and comply with MIL-STD-2073-1E and Special Packaging Instructions MPPWN00001, while labeling must adhere to Medical Marking Standard No. 1B. Inspection and acceptance will occur at the destination per FAR 52.246-2. Invoicing and payment must be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0270

Solicitation SPE2DP-27-T-0270 is a Small Business Set-Aside procurement issued by the Defense Logistics Agency for the acquisition of 10 bottles of Gabapentin Capsules, 100 MG, in quantities of 100 per bottle. This FDA-regulated drug must be stored at 25C with permitted excursions between 15C and 30C per USP Controlled Room Temperature standards. The item has a non-extendable shelf life of 36 months. Delivery is required FOB Destination to a medical detachment in Washington, DC, with a required delivery date of November 12, 2026. The contract mandates commercial packaging and packing, requiring each unit to be in a sealed container to prevent damage, with shipping containers ensuring safe delivery. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Inspection and acceptance will occur at the destination. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and payment. The procurement incorporates various FAR and DFARS clauses, including the Buy American Act, NIST SP 800-171 cybersecurity requirements, and strict prohibitions on covered defense telecommunications equipment.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Labeling and Barcoding ServicesThis subcontract for Pharmaceutical Labeling and Barcoding Services involves the final packaging and preparation of Nitroglycerin patches for prime contractors serving the Department of Veterans Affairs and the Department of Defense. The scope of work includes boxing patches in 30-unit quantities, applying barcodes to both individual patches and outer boxes, and ensuring all unique NDC labels comply with FDA regulations. A critical requirement is that label adhesion must be managed to allow for subsequent VA over-labeling. The project is managed under Nac Pharmaceuticals for the Department of Veterans Affairs, falling under NAICS code 325412. The objective is to deliver retail-ready, fully barcoded, and labeled boxes of patches that meet all federal and agency specifications.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

Nitroglycerin Transdermal Patch ManufacturingNac Pharmaceuticals is seeking a subcontractor to manufacture and supply Nitroglycerin transdermal patches in strengths of 0.1 mg, 0.2 mg, 0.4 mg, and 0.6 mg. These products are intended for prime contractors supporting Department of Veterans Affairs pharmaceutical supply contracts. The manufacturing process must utilize pharmaceutical grade Nitroglycerin API and adhere to FAR Part 12 commercial item standards. To be eligible, the provider must operate FDA-approved manufacturing facilities and ensure each product has a unique National Drug Code number. This subcontract opportunity falls under NAICS code 325412, with a response deadline of November 18, 2026.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

6505--Nitroglycerin Patches

Solicitation # 36E79727R0010

The Department of Veterans Affairs National Acquisition Center is initiating an unrestricted procurement for Nitroglycerin Patches under solicitation 36E79727R0010. This contract will serve the VA, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The award will be granted to a single responsible offeror capable of providing an uninterrupted source of supply for a one-year base period followed by four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. The procurement covers four strengths of Nitroglycerin patches (0.1 mg, 0.2 mg, 0.4 mg, and 0.6 mg), with estimated annual usage ranging from 2,213 to 10,044 boxes. All patches must be supplied in boxes of 30 and must feature barcoding on both the individual patch and the outside box. Strict labeling requirements apply: the contractor must provide a unique NDC number, and their label must be the only one on the product, without being affixed over another label. Additionally, the labels must allow VA labels to adhere securely over them. This solicitation will be issued in commercial item format per FAR Part 12, with a tentative issuance date of December 1, 2026, and a closing date of December 15, 2026.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

6505--AREDS2 ophthalmic multivitamins

Solicitation # 36E79727R0009

The Department of Veterans Affairs National Acquisition Center is initiating an unrestricted procurement under solicitation 36E79727R0009 for MULTIVIT/OPHTH AREDS2/LUTEIN/ZEAXANTHIN capsules or tablets. This contract is designed to provide an uninterrupted source of supply for the Department of Veterans Affairs, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The estimated annual requirement is 829,230 bottles of 120-count packaging, with distribution managed through the respective Pharmaceutical Prime Vendor Programs of the VA and DoD. The contract will be awarded to a single responsible offeror for a base period of one year, followed by four pre-priced one-year option periods. The procurement follows FAR Part 12 commercial item format under NAICS code 325412. Strict labeling requirements apply: the contractor must provide a unique NDC number, and their label must be the only one on the product, with a prohibition against affixing labels over existing ones. The solicitation is expected to be issued electronically via SAM.gov on approximately December 23, 2026, with a tentative closing date of January 13, 2027.

Nac Pharmaceuticals (36E797)

POSTED

about 18 hours ago

DEADLINE

N/A

AI Contract Overview

Defense Logistics Agency award SPE2D926F8450 is a delivery order issued on August 28, 2026, under the broader commercial items contract SPE2DX25D8022. The order was awarded to Cardinal Health, Inc. for the procurement of 8,000 bottles of Meclizine Hydrochloride Tablets, identified by NSN 6505009262111. This specific delivery is designated for the USNS Wally Schirra T-AKE 8, with a total order price of 19.44 dollars. The overarching contract, SPE2DX25D8022, was originally issued by the DLA Troop Support Medical Supply Chain on March 7, 2025, following solicitation SPE2DX24R0001. This master agreement has a total award value of 20,000,000 dollars and falls under NAICS code 325412 for pharmaceutical preparation. The contract is governed by FAR 52.212 regulations and utilizes a Fleet milstrip contract arrangement for the distribution of commercial medical supplies.

General Info

DLA awarded Cardinal Health 19.44 dollars for 8,000 Meclizine Hydrochloride Tablets.

Agency

Department Of Defense → Defense Logistics Agency

Contract Value

$19.44

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Awardee

CARDINAL HEALTH, INC.

Award Issued Date

08/28/2026, 12:00:00 AM UTC

Documents

award

High

task-order-award

High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded

PostedAug 28

Award Notice

AwardedAug 28

Contract was awarded

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → Defense Logistics Agency

ContactsNo contacts available

OfficeUSA

Organization / AgencyDepartment Of Defense → Defense Logistics Agency

Office AddressUSA

ContactsNo contact information available

Full Description

DLA award SPE2D926F8450 posted on DIBBS. Awardee: CARDINAL HEALTH, INC. (CAGE 00E55) Total Contract Price: $19.44 Award Date: 08-28-2026 Delivery order under: SPE2DX25D8022 Line items: - MECLIZINE HYDROCHLORIDE TABLETS (NSN/Part 6505009262111, PR 7018104491)